The European Union’s Medical Device Regulation (MDR) has introduced a new document that is causing disproportionate headaches for Regulatory Affairs teams worldwide: the Summary of Safety and Clinical Performance (SSCP). Mandated by Article 32 for implantable and Class III devices, the SSCP is intended to increase transparency in the MedTech sector. It must be uploaded to EUDAMED and accessible to the public.
But there is a catch—a clause that is rapidly becoming a compliance trap for the unprepared. The regulation explicitly requires that a portion of this document be written in a way that is clear to the intended user and, if relevant, to the patient.
For manufacturers of Class III custom-made devices facing the May 2026 deadline, this layperson summary is a critical vulnerability. If a Notified Body auditor determines that your Swedish patient summary is too technical, or your Italian summary is ambiguous, they will flag it as a non-conformity. In the current bottleneck, that flag could cost you your market access.
Medical professionals speak a specific, high-context language. Patients do not. The Medical Device Coordination Group (MDCG) guidance document MDCG 2019-9 explicitly recommends that patient summaries be written at a reading level suitable for a 12-year-old.
Achieving this in English is difficult enough. But when you translate a simplified English summary into German, Finnish or Hungarian, the reading level often drifts upward.
Why does this matter now? Because the regulatory squeeze has removed the margin for error. Notified Bodies are under immense pressure to clear the backlog before the 2026/2027/2028 deadlines. They do not have the bandwidth to coach manufacturers through multiple rounds of revisions. A file with linguistic errors is an easy file to reject. It allows the auditor to clear a case from their desk and move to the next one.
Translation is no longer enough. To ensure MDR compliance, you must apply linguistic validation protocols—the same rigorous standards used for Clinical Outcome Assessments (COAs).
Our 4-step validation workflow includes:
With the non-negotiable May 2026 deadline looming, your organization requires a risk mitigation partner that understands the high-stakes nature of the medical device industry. At Responsive Translation, we specialize in providing the accurate and HIPAA-compliant services necessary to protect patient safety and ensure international regulatory success. As an ISO 13485 and ISO 9001-certified provider, we offer scalable language solutions that integrate psychometric integrity and rigorous quality assurance to help you pass Notified Body review the first time. We have over three decades of experience serving compliance-intensive industries where error isn’t an option. Your clinical data is solid and your device is safe—don’t let your words be the weak link. Trust the team ranked first in the world for customer satisfaction to deliver the right translation right now.
Request a custom proposal or schedule your free consultation today.